Trethera (Formerly Triangle Therapeutics)
Small molecules that control dna replication and integrity.
Launch date
Employees
Market cap
-
Enterprise valuation
€27—40m (Dealroom.co estimates Feb 2016.)
Beverly Hills California (HQ)
Authorizing premium user...